Clal Biotechnology Industries Ltd (CBI) — Financial Flexibility Index
Clal Biotechnology Industries Ltd (CBI) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA19.52 Million). Also explore Clal Biotechnology Industries Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clal Biotechnology Industries Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Clal Biotechnology Industries Ltd across 19 annual periods. Check strategic asset allocation of Clal Biotechnology Industries Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Clal Biotechnology Industries Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Clal Biotechnology Industries Ltd. For the full company profile including market capitalisation, see how much is Clal Biotechnology Industries Ltd worth.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA-6.48 Million | ILA21.52 Million | ▼ -30.8% |
| 2023 | -0.23x | ILA-8.51 Million | ILA-8.51 Million | ILA36.98 Million | ▲ +84.9% |
| 2022 | -1.53x | ILA-57.76 Million | ILA-59.04 Million | ILA37.79 Million | ▼ -309.9% |
| 2021 | -0.37x | ILA-39.73 Million | ILA-41.33 Million | ILA106.55 Million | ▼ -24.4% |
| 2020 | -0.30x | ILA-30.04 Million | ILA-33.23 Million | ILA100.24 Million | ▼ -219.6% |
| 2019 | 0.25x | ILA29.86 Million | ILA27.03 Million | ILA119.12 Million | ▲ +144.3% |
| 2018 | -0.57x | ILA-84.03 Million | ILA-86.98 Million | ILA148.46 Million | ▼ -47.6% |
| 2017 | -0.38x | ILA-86.72 Million | ILA-91.41 Million | ILA226.14 Million | ▼ -30.5% |
| 2016 | -0.29x | ILA-107.65 Million | ILA-112.63 Million | ILA366.21 Million | ▲ +4.8% |
| 2015 | -0.31x | ILA-135.94 Million | ILA-147.00 Million | ILA440.31 Million | ▼ -15.9% |
| 2014 | -0.27x | ILA-114.14 Million | ILA-115.95 Million | ILA428.44 Million | ▲ +2.2% |
| 2013 | -0.27x | ILA-147.25 Million | ILA-148.98 Million | ILA540.45 Million | ▼ -21.8% |
| 2012 | -0.22x | ILA-79.22 Million | ILA-81.22 Million | ILA354.19 Million | ▲ +68.8% |
| 2011 | -0.72x | ILA-101.82 Million | ILA-102.45 Million | ILA142.01 Million | ▲ +7.4% |
| 2010 | -0.77x | ILA-107.00 Million | ILA-111.93 Million | ILA138.20 Million | ▼ -54.0% |
| 2009 | -0.50x | ILA-77.13 Million | ILA-86.86 Million | ILA153.41 Million | ▼ -49.3% |
| 2008 | -0.34x | ILA-50.99 Million | ILA-52.41 Million | ILA151.47 Million | ▲ +17.8% |
| 2007 | -0.41x | ILA-45.45 Million | ILA-47.05 Million | ILA110.98 Million | ▲ +77.4% |
| 2006 | -1.81x | ILA-22.67 Million | ILA-23.55 Million | ILA12.50 Million | — |